Literature DB >> 12112083

Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume.

Erina M Schumann1, Tania Kümpfel, Florian Then Bergh, Claudia Trenkwalder, Florian Holsboer, Dorothee P Auer.   

Abstract

The known interaction between the immune system and the hypothalamic-pituitary-adrenal axis led us to explore the interrelation between magnetic resonance imaging findings and the hypothalamic-pituitary-adrenal axis activity in 53 multiple sclerosis patients. The cortisol release induced by the dexamethasone-corticotropin-releasing hormone test was negatively associated with the presence and number of gadolinium-enhancing lesions and positively associated with ventricular size. This finding suggests a protective effect of the hypothalamic- pituitary-adrenal drive on acute lesional inflammation in multiple sclerosis, probably by limiting immune overshoot. In contrast, the nature of the correlation between hypothalamic-pituitary-adrenal hyperdrive and brain atrophy remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112083     DOI: 10.1002/ana.10187

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

Review 1.  Exercise and brain health--implications for multiple sclerosis: Part II--immune factors and stress hormones.

Authors:  Lesley J White; Vanessa Castellano
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

2.  Biological outcome measurements for behavioral interventions in multiple sclerosis.

Authors:  Anja Fischer; Christoph Heesen; Stefan M Gold
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

3.  Stress-induced brain activity, brain atrophy, and clinical disability in multiple sclerosis.

Authors:  Martin Weygandt; Lil Meyer-Arndt; Janina Ruth Behrens; Katharina Wakonig; Judith Bellmann-Strobl; Kerstin Ritter; Michael Scheel; Alexander U Brandt; Christian Labadie; Stefan Hetzer; Stefan M Gold; Friedemann Paul; John-Dylan Haynes
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

4.  Effect of childhood emotional abuse and age on cortisol responsivity in adulthood.

Authors:  Linda L Carpenter; Audrey R Tyrka; Nicole S Ross; Lamya Khoury; George M Anderson; Lawrence H Price
Journal:  Biol Psychiatry       Date:  2009-04-17       Impact factor: 13.382

5.  Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.

Authors:  Florian Then Bergh; Tania Kümpfel; Erina Schumann; Ulrike Held; Michaela Schwan; Mirjana Blazevic; Axel Wismüller; Florian Holsboer; Alexander Yassouridis; Manfred Uhr; Frank Weber; Martin Daumer; Claudia Trenkwalder; Dorothee P Auer
Journal:  BMC Neurol       Date:  2006-05-23       Impact factor: 2.474

6.  Adverse Childhood Experiences Are Linked to Age of Onset and Reading Recognition in Multiple Sclerosis.

Authors:  Michael T Shaw; Natalie O Pawlak; Ariana Frontario; Kathleen Sherman; Lauren B Krupp; Leigh E Charvet
Journal:  Front Neurol       Date:  2017-06-02       Impact factor: 4.003

7.  Transcriptome analysis of normal-appearing white matter reveals cortisol- and disease-associated gene expression profiles in multiple sclerosis.

Authors:  Jeroen Melief; Marie Orre; Koen Bossers; Corbert G van Eden; Karianne G Schuurman; Matthew R J Mason; Joost Verhaagen; Jörg Hamann; Inge Huitinga
Journal:  Acta Neuropathol Commun       Date:  2019-04-25       Impact factor: 7.801

8.  Blunted neural and psychological stress processing predicts future grey matter atrophy in multiple sclerosis.

Authors:  Lil Meyer-Arndt; Stefan Hetzer; Susanna Asseyer; Judith Bellmann-Strobl; Michael Scheel; Jan-Patrick Stellmann; Christoph Heesen; Andreas K Engel; Alexander U Brandt; John-Dylan Haynes; Friedemann Paul; Stefan M Gold; Martin Weygandt
Journal:  Neurobiol Stress       Date:  2020-07-27

9.  Stress-Axis Regulation by Vitamin D3 in Multiple Sclerosis.

Authors:  Linda Rolf; Jan Damoiseaux; Inge Huitinga; Dorien Kimenai; Jody van den Ouweland; Raymond Hupperts; Joost Smolders
Journal:  Front Neurol       Date:  2018-04-26       Impact factor: 4.003

10.  The Role of Stress Perception and Coping with Stress and the Quality of Life Among Multiple Sclerosis Patients.

Authors:  Aleksandra Kołtuniuk; Magdalena Kazimierska-Zając; Kinga Cisek; Justyna Chojdak-Łukasiewicz
Journal:  Psychol Res Behav Manag       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.